Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.

作者信息

Au W Y, Fung A, Lie A K, Lam K Y, Lam C C, Kwong Y L

出版信息

Ann Hematol. 2007 Feb;86(2):145-7. doi: 10.1007/s00277-006-0213-2. Epub 2006 Nov 17.

DOI:10.1007/s00277-006-0213-2

PMID:17111143

Abstract

摘要

相似文献

Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis.

Ann Hematol. 2007 Feb;86(2):145-7. doi: 10.1007/s00277-006-0213-2. Epub 2006 Nov 17.

Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain.

Haematologica. 2008 Sep;93(9):1412-4. doi: 10.3324/haematol.12970. Epub 2008 Jul 18.

Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia.

Int J Hematol. 2008 May;87(4):446-448. doi: 10.1007/s12185-008-0080-9.

Clinical relevance of JAK2 (V617F) mutant allele burden.

Haematologica. 2009 Jan;94(1):7-10. doi: 10.3324/haematol.2008.001271.

Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.

Leuk Res. 2011 Sep;35(9):1188-92. doi: 10.1016/j.leukres.2011.02.001. Epub 2011 Mar 3.

Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation.

Bone Marrow Transplant. 2006 Oct;38(8):573-4. doi: 10.1038/sj.bmt.1705482. Epub 2006 Sep 4.

No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1350-1. doi: 10.1016/j.bbmt.2006.07.010.

JAK2 V617F-positive essential thrombocythemia in a patient with Klinefelter syndrome: a case report.

Cancer Genet Cytogenet. 2010 Apr 15;198(2):162-5. doi: 10.1016/j.cancergencyto.2010.01.001.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].

Orv Hetil. 2006 Nov 12;147(45):2175-9.

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.

Blood. 2008 Apr 15;111(8):3931-40. doi: 10.1182/blood-2007-08-107748. Epub 2007 Dec 26.

引用本文的文献

negative acute monocytic leukemia with TET2 mutation in essential thrombocythemia with mutation with literature review.

Leuk Res Rep. 2020 Jan 16;13:100194. doi: 10.1016/j.lrr.2019.100194. eCollection 2020.

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation.

Case Rep Hematol. 2015;2015:703457. doi: 10.1155/2015/703457. Epub 2015 Aug 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验